These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6344545)

  • 1. Prostaglandins and the non-pregnant uterus. The pathophysiology of primary dysmenorrhea.
    Pulkkinen MO
    Acta Obstet Gynecol Scand Suppl; 1983; 113():63-7. PubMed ID: 6344545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of dysmenorrhea.
    Akerlund M
    Acta Obstet Gynecol Scand Suppl; 1979; 87():27-32. PubMed ID: 380250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rationale for the treatment of dysmenorrhea.
    Csapo AI
    J Reprod Med; 1980 Oct; 25(4 Suppl):213-21. PubMed ID: 7001020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of uterine contractility after administration of the non-steroidal anti-inflammatory drug nimesulide.
    Pulkkinen M; Monti T; Macciocchi A
    Acta Obstet Gynecol Scand; 1992 Apr; 71(3):181-5. PubMed ID: 1317639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menstrual pain: its origin and pathogenesis.
    Rosenwaks Z; Seegar-Jones G
    J Reprod Med; 1980 Oct; 25(4 Suppl):207-12. PubMed ID: 7001019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-uterine pressure in dysmenorrhea.
    Lumsden MA; Baird DT
    Acta Obstet Gynecol Scand; 1985; 64(2):183-6. PubMed ID: 3984694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspects of inhibition of myometrial hyperactivity in primary dysmenorrhea.
    Forman A; Ulmsten U; Andersson KE
    Acta Obstet Gynecol Scand Suppl; 1983; 113():71-6. PubMed ID: 6134424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction.
    Sun L; Liu L; Zong S; Wang Z; Zhou J; Xu Z; Ding G; Xiao W; Kou J
    J Ethnopharmacol; 2016 Sep; 191():273-279. PubMed ID: 27340106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
    Lalos O; Joelsson I
    Acta Obstet Gynecol Scand; 1981; 60(3):229-32. PubMed ID: 7270089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysmenorrhea.
    Dawood MY
    J Reprod Med; 1985 Mar; 30(3):154-67. PubMed ID: 3158737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of nimesulide and naproxen on the uterine and ovarian arterial blood flow velocity. A Doppler study.
    Pirhonen J; Pulkkinen M
    Acta Obstet Gynecol Scand; 1995 Aug; 74(7):549-53. PubMed ID: 7618455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressure-velocity analysis of uterine muscle during spontaneous dysmenorrheic contractions in vivo.
    Smith RP
    Am J Obstet Gynecol; 1989 Jun; 160(6):1400-3; discussion 1403-5. PubMed ID: 2735366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ge-Gen Decoction attenuates oxytocin-induced uterine contraction and writhing response: potential application in primary dysmenorrhea therapy.
    Yang L; Chai CZ; Yue XY; Yan Y; Kou JP; Cao ZY; Yu BY
    Chin J Nat Med; 2016 Feb; 14(2):124-132. PubMed ID: 26968678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Inhibitory Effect of Extra Virgin Olive Oil and Its Active Compound Oleocanthal on Prostaglandin-Induced Uterine Hypercontraction and Pain-Ex Vivo and In Vivo Study.
    Chiang YF; Hung HC; Chen HY; Huang KC; Lin PH; Chang JY; Huang TC; Hsia SM
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 33008039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive.
    Hauksson A; Akerlund M; Forsling ML; Kindahl H
    J Endocrinol; 1987 Nov; 115(2):355-61. PubMed ID: 3125302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a vasopressin antagonist in women with dysmenorrhea.
    Valentin L; Sladkevicius P; Kindahl H; Broeders A; Marsal K; Melin P
    Gynecol Obstet Invest; 2000; 50(3):170-7. PubMed ID: 11014949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an oral contraceptive in primary dysmenorrhea--changes in uterine activity and reactivity to agonists.
    Ekström P; Juchnicka E; Laudanski T; Akerlund M
    Contraception; 1989 Jul; 40(1):39-47. PubMed ID: 2505970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does aerobic exercise induced-analgesia occur through hormone and inflammatory cytokine-mediated mechanisms in primary dysmenorrhea?
    Kannan P; Cheung KK; Lau BW
    Med Hypotheses; 2019 Feb; 123():50-54. PubMed ID: 30696591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PGI2 may play a role in the pathophysiology of dysmenorrhea.
    Wilhelmsson L; Lindblom B; Wikland M; Hamberger L; Norström A; Wiqvist N
    Acta Obstet Gynecol Scand Suppl; 1983; 113():69-70. PubMed ID: 6344546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea.
    Strömberg P; Akerlund M; Forsling ML; Granström E; Kindahl H
    Acta Obstet Gynecol Scand; 1984; 63(6):533-8. PubMed ID: 6542295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.